Clinical Trial

AB-1005 Long-Term Follow-up Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-21.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-09-29
Trial Details
NCT Number NCT07081841
Lead Sponsor AskBio Inc
Conditions Parkinson's Disease, Multiple System Atrophy, Parkinson Variant
Enrollment 132 participants
Start Date 2025-09-04
Primary Completion 2037-09-30 (estimated)
Study Completion 2038-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-02